Remdesivir for Patients Hospitalized With COVID-19: Evidence of Effectiveness From Cohort Studies in the Omicron Era.

The article focuses on the effectiveness of remdesivir for hospitalized COVID-19 patients during the Omicron era, based on cohort studies. Topics include the challenges of conducting clinical trials during a global pandemic, the outcomes of previous randomized trials on remdesivir, and evidence from real-world cohort studies regarding its impact on patient recovery.